与CDKN2突变相关的导管胰腺腺癌患者生存率降低。 - Suppr

Suppr

超能文献

Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation.

作者信息

Bartsch D, Shevlin D W, Callery M P, Norton J A, Wells S A, Goodfellow P J

机构信息

Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

J Natl Cancer Inst. 1996 May 15;88(10):680-2. doi: 10.1093/jnci/88.10.680.

DOI:10.1093/jnci/88.10.680

PMID:8627645

Abstract

摘要

相似文献

Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation.与CDKN2突变相关的导管胰腺腺癌患者生存率降低。

J Natl Cancer Inst. 1996 May 15;88(10):680-2. doi: 10.1093/jnci/88.10.680.

Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.对人胰腺导管癌中P16/MTS-1肿瘤抑制基因的缺失和突变分析显示，肿瘤衍生细胞系中异常的频率高于原发性导管腺癌。

Cancer Res. 1996 Mar 1;56(5):1137-41.

A new platform for gene discovery in pancreatic cancer.

Gastroenterology. 2005 Aug;129(2):763-4. doi: 10.1016/j.gastro.2005.05.069.

Tumor-suppressor genes in pancreatic cancer.胰腺癌中的肿瘤抑制基因。

J Hepatobiliary Pancreat Surg. 1998;5(4):383-91. doi: 10.1007/s005340050062.

Molecular genetic basis of pancreatic adenocarcinoma.

Genes Chromosomes Cancer. 1999 Sep;26(1):1-12.

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.简短报告：一种伴有CDKN2肿瘤抑制基因突变的胰腺癌和黑色素瘤家族综合征。

N Engl J Med. 1995 Oct 12;333(15):975-7. doi: 10.1056/NEJM199510123331505.

MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.MTS-1（CDKN2）肿瘤抑制基因缺失在食管鳞状细胞癌和胰腺腺癌细胞系中是常见事件。

Oncogene. 1995 Feb 2;10(3):619-22.

Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.胰腺癌中DPC4表达缺失及其与临床病理参数的相关性

World J Gastroenterol. 2003 Dec;9(12):2764-7. doi: 10.3748/wjg.v9.i12.2764.

Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.外分泌性胰腺肿瘤癌症遗传学的最新发现。

Digestion. 1998 Aug;59(5):493-501. doi: 10.1159/000007526.

Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer.基于吉西他滨的胰腺癌治疗的基因组检测

J Natl Cancer Inst. 2016 Feb 8;108(5). doi: 10.1093/jnci/djv424. Print 2016 May.

引用本文的文献

Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer.p16蛋白表达缺失及p53蛋白异常表达在胰腺癌中的临床意义

Yonsei Med J. 2005 Aug 31;46(4):519-25. doi: 10.3349/ymj.2005.46.4.519.

Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma.胰腺导管癌中肿瘤抑制基因p16INK4a的改变。

BMC Gastroenterol. 2005 Jun 28;5:22. doi: 10.1186/1471-230X-5-22.

Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.启动子高甲基化及CDKN2A基因540 C>T多态性在垂直生长期皮肤黑色素瘤中的显著影响。

Am J Pathol. 2002 Jul;161(1):229-37. doi: 10.1016/S0002-9440(10)64174-0.

p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.p16INK4a是切除的导管胰腺癌的一个预后标志物：p16INK4a、p53、MDM2和Rb的分析

Ann Surg. 2002 Jan;235(1):51-9. doi: 10.1097/00000658-200201000-00007.

K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.K-ras癌基因突变表明胰腺囊性肿瘤具有恶性特征。

Ann Surg. 1998 Jul;228(1):79-86. doi: 10.1097/00000658-199807000-00012.

The CDKN2A (p16) gene and human cancer.CDKN2A（p16）基因与人类癌症。

Mol Med. 1997 Jan;3(1):5-20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验